Lana Medical Co. (9587.SR) — Cash flow
Operating, investing, and financing cash flow for Lana Medical Co. — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 3↓80.2% | 14↑352.5% | 3↓45.2% | 5↓16.7% | 7 | |
| Depreciation & Amortization | 6↑63.2% | 4 | 0.00↓100.0% | 2↑41.7% | 1 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -14↓16.6% | -12↓40.6% | -9↓122.0% | -4↑72.0% | -14 | |
| Accounts Receivable | -11↑33.6% | -17↓80.2% | -9↓115.8% | -4↑72.3% | -16 | |
| Inventory | -6↓442.2% | -1↓54.9% | -0.77↓4507.7% | -0.02↓102.4% | 0.70 | |
| Accounts Payable | 10 | 0.00↓100.0% | 3↑6823.3% | -0.04↓109.5% | 0.40 | |
| Other Working Capital | -6↓209.2% | 6↑632.2% | -1↓323.8% | 0.50↓23.9% | 0.65 | |
| Other Non-Cash Items | -3↑30.1% | -5↓163.9% | 7↑202.8% | 2↑73.7% | 1 | |
| Net Cash from Operating Activities | -9↓2382.5% | 0.39↓72.5% | 1↓73.8% | 5↑210.2% | -5 | |
| Operating Cash Flow | -9↓2382.5% | 0.39↓72.5% | 1↓73.8% | 5↑210.2% | -5 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -5↓14.8% | -4↓12.6% | -4↑28.2% | -5↑29.4% | -7 | |
| Capital Expenditure | -5↓14.8% | -4 | 0.00↑100.0% | -5↑29.4% | -7 | |
| Acquisitions | 1↑111.7% | -11↓6062.9% | 0.18 | 0.00↓100.0% | 0.01 | |
| Purchases of Investments | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales & Maturities of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 0.00↓100.0% | 0.01↑102.6% | -0.56 | 0.00↓100.0% | 0.11 | |
| Net Cash from Investing Activities | -4↑76.0% | -15↓262.2% | -4↑20.6% | -5↑28.2% | -7 | |
| Financing Activities | ||||||
| Net Debt Issuance | 13↑316.0% | 3↑159.0% | 1↑743.8% | -0.19↑81.5% | -1 | |
| Long-Term Net Debt Issuance | 13↑316.0% | 3↑159.0% | 1↑743.8% | -0.19↑81.5% | -1 | |
| Short-Term Net Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Stock Issuance | 0.00 | 0.00↓100.0% | 18 | 0.00↓100.0% | 13 | |
| Net Common Stock Issuance | 0.00 | 0.00↓100.0% | 18 | 0.00↓100.0% | 13 | |
| Common Stock Issuance | 0.00 | 0.00↓100.0% | 18 | 0.00↓100.0% | 13 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -2↓86.2% | -1↓94.1% | -0.65↓72.5% | -0.38 | 0.00 | |
| Net Cash from Financing Activities | 11↑472.8% | 2↓89.7% | 18↑3283.3% | -0.57↓104.7% | 12 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | -2↑85.3% | -12↓180.3% | 15↑7384.7% | -0.21↓237.0% | -0.06 | |
| Cash at Beginning of Period | 6↓66.1% | 19↑467.8% | 3↓6.0% | 4↓1.8% | 4 | |
| Cash at End of Period | 5↓28.7% | 6↓66.1% | 19↑467.8% | 3↓6.0% | 4 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | -14↓267.7% | -4↓361.0% | 1↑301.7% | 0.36↑102.9% | -12 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.